Acetazolamide
Acetazolamide (Diamox) prevents AMS when taken before ascent and can
speed recovery if taken after symptoms have developed. The drug
works by acidifying the blood, which causes an increase in
respiration and thus aids acclimatization. An effective dose that
minimizes the common side effects of increased urination and
paresthesias of the fingers and toes is 125 mg every 12 hours,
beginning the day before ascent and continuing the first 2 days at
altitude, or longer if ascent continues. Allergic reactions to
acetazolamide are uncommon, but the drug is related to sulfonamides
and should not be used by sulfa-allergic persons with history of
anaphylaxis. A
trial dose taken in a safe environment before travel may be useful
for those with a more mild allergic history to sulfonamides. People
with history of severe penicillin allergy have occasionally had
allergic reactions to acetazolamide.
Dexamethasone
Dexamethasone is very effective for prevention and treatment of AMS
and HACE, and perhaps HAPE as well. Unlike acetazolamide, rebound
can occur if the drug is discontinued at altitude prior to
acclimatization. Acetazolamide is preferable to prevent AMS while
ascending, with dexamethasone reserved for treatment during descent.
Adult dosage is 4 mg every 6 hours.
HAPE is always associated with increased
pulmonary artery
pressure, and pulmonary vasodilators are useful for
preventing and treating HAPE.
Nifedipine
Nifedipine prevents and ameliorates HAPE in persons who are
particularly susceptible to the condition. The adult dosage is 20 mg
of extended release every 8–12 hours. PDE-5 inhibitors can also
selectively lower pulmonary artery pressure, with less effect on
systemic blood
pressure.
Other Medications
Tadalafil (Cialis), 10 mg twice a day, during ascent can prevent
HAPE and is being studied for treatment. When taken before ascent,
gingko biloba, 100–120 mg twice daily, was shown to reduce AMS in
adults in some trials, but it was not effective in others, probably
due to variation in ingredients. Gingko biloba has not yet been
compared directly with acetazolamide.